Coastlands Capital LP Acquires ADIL Common Stock

On June 29, 2026, Coastlands Capital LP, a significant shareholder, acquired 25,000 shares of ADIAL PHARMACEUTICALS, INC. (ADIL) common stock at a price of $2.60 per share. This transaction brings Coastlands Capital LP's total holdings to 373,322 shares. The filing indicates that Coastlands Capital LP is the investment adviser and general partner of related entities, with Matthew Perry identified as a control person. The reporting persons have jointly filed this Form 4, disclaiming membership in a group and beneficial ownership beyond their pecuniary interest.